10-meter walk test: Guide and downloadable scoring template

Key Takeaways

The 10-meter walk test measures gait speed (m/s) over a standardized distance; timing captures the middle 6 meters to exclude acceleration and deceleration phases.

Normal gait speed for healthy adults is 1.3-1.5 m/s; speeds below 0.8 m/s indicate elevated fall risk and functional decline.

The test is applicable across stroke, Parkinson’s disease, spinal cord injury, traumatic brain injury, and dementia populations with population-specific norm tables.

Pabau’s digital forms and client record features enable clinicians to document 10MWT results, track longitudinal speed changes, and auto-populate assessment data into clinical notes.

Download your 10-meter walk test scoring template

What is the 10-meter walk test?

The 10-meter walk test (10MWT) is a simple, quick clinical assessment that measures walking speed in meters per second (m/s). A patient walks 10 meters without assistance, and clinicians record the time taken to cover the middle 6 meters. This approach allows natural acceleration at the start and deceleration at the end, capturing steady-state gait speed rather than transition phases.

Gait speed is increasingly recognized as a “sixth vital sign” in geriatric and rehabilitation medicine-a strong, independent indicator of overall health status, functional independence, and fall risk. The 10MWT is used across multiple clinical populations: stroke recovery, Parkinson’s disease, spinal cord injury (SCI), traumatic brain injury (TBI), dementia, orthopedic rehabilitation, and general fall-risk screening.

The test requires minimal equipment (a 10-metre hallway, marked at 0, 2, 8, and 10 meters, plus a stopwatch) and takes under 5 minutes to administer. It provides actionable data for treatment planning, progress monitoring, and clinical decision-making. The American Physical Therapy Association (APTA) endorses the 10MWT as an evidence-based outcome measure for multiple patient populations.

One important limitation: the 10MWT measures walking speed only and does not account for the amount of physical assistance required. A patient may achieve a certain velocity while relying on a walker, cane, or tactile cuing from a clinician-factors the test does not capture.

How to perform the 10-meter walk test

Standardized administration ensures reliable, comparable results across sessions and clinicians. Follow these five operational steps:

1. Set up the walkway: Use a flat, unobstructed hallway or corridor. Mark the floor at 0, 2, 8, and 10 meters using tape or chalk. The 2-meter mark marks the start of timing; the 8-meter mark marks the end of timing. This excludes the first 2 meters (acceleration phase) and final 2 meters (deceleration phase) from the measurement.
2. Position the patient: Have the patient stand at the start line (0-meter mark) facing the direction of travel. They should be in their typical walking posture-with or without assistive device as needed for safe, independent ambulation. Provide clear, consistent instructions: “Walk at your normal, comfortable pace from here to the end of the hallway.”
3. Start timing: Begin the stopwatch when the patient’s leading foot crosses the 2-metre mark. This signals steady-state gait.
4. Record time: Stop the stopwatch when the patient’s leading foot crosses the 8-metre mark. Record the time to the nearest 0.01 second if using a digital stopwatch.
5. Calculate speed: Distance walked = 6 meters. Speed (m/s) = 6 meters ÷ time (seconds). For example, if the patient took 4.5 seconds to walk 6 meters, their gait speed = 6 ÷ 4.5 = 1.33 m/s.

Conduct at least two trials and record the average. If results vary significantly (>0.1 m/s difference), a third trial may clarify the patient’s typical performance. Document which walking aid (if any) was used, as this affects interpretation.

Normal values and interpretation thresholds

Normal gait speed varies by age, health status, and baseline mobility. The following reference ranges guide clinical interpretation:

Speeds below 0.8 m/s consistently predict increased fall risk, loss of independence, and higher mortality across geriatric and neurological populations. This threshold guides clinical decisions about balance training, mobility aids, home safety modifications, and care escalation.

Population-specific norms differ by diagnosis. For example, post-stroke patients may show average speeds of 0.7-1.0 m/s depending on time since stroke and severity. Parkinson’s disease patients often show reduced speed due to bradykinesia (slow movement). Check the Shirley Ryan AbilityLab RehabMeasures Database for population-specific norm tables and minimal detectable change (MDC) values.

Book a demo to streamline your 10-meter walk test documentation

Integrate gait speed measurements directly into patient records. Pabau’s measurement tracking features allow you to record test results, set baseline values, and monitor progress over weeks or months. Automated client records keep all assessment data in one secure place, reducing manual entry and improving compliance with clinical documentation standards.

Simplify outcome measure tracking with Pabau

Centralise patient assessments, automate clinical documentation, and track functional progress over time-all in one practice management platform.

Book a demo

Who uses the 10-meter walk test?

The 10MWT is a core assessment tool across multiple healthcare disciplines:

• Physical therapists: Use the 10MWT to assess post-surgical mobility (hip/knee arthroplasty), lower-limb function after injury, and progress in gait retraining. The test guides decisions about discharge readiness and intensity of ongoing therapy.
• Occupational therapists: Integrate gait speed assessment into broader functional mobility evaluations, especially for older adults or those transitioning to community living. A digital patient record centralizes assessment data for comprehensive care planning.
• Neurological rehabilitation specialists: Measure the impact of stroke, Parkinson’s disease, TBI, or spinal cord injury on walking capacity. Serial 10MWT results document neuroplastic recovery and guide rehabilitation intensity.
• Sports medicine and athletic trainers: Assess return-to-sport readiness after lower-limb injury by comparing post-injury gait speed to baseline or normative values.
• Geriatricians and primary care physicians: Screen for fall risk and functional decline in older adults as part of annual checkups, frailty assessment, and preventive care protocols.

Benefits of using the 10-meter walk test

Simplicity and efficiency: The test takes under 5 minutes, requires no expensive equipment, and provides immediate numerical data. Clinicians can administer it in any hallway, making it practical for busy clinics and community settings.

Evidence-based outcome measure: The 10MWT has demonstrated test-retest reliability and validity across stroke, Parkinson’s disease, SCI, and TBI populations. Clinicians can confidently use results to justify treatment intensity and document functional change.

Predictive value for falls and mortality: Gait speed is a strong predictor of fall risk, hospitalization, and long-term survival. A single measurement provides actionable clinical intelligence for risk stratification and intervention planning.

Progress monitoring and accountability: Serial 10MWT results create a transparent record of functional change, supporting patient motivation and clinician accountability. Combined with digital intake forms and automated clinical notes, the test becomes part of a coherent outcome measurement system.

Protocol variations across populations

While the standardized 10-meter walking distance applies universally, specific protocols vary by patient population to ensure safety and valid measurement:

Neurologically impaired patients: Clinicians may provide tactile cuing, verbal encouragement, or manual contact to ensure safe walking. The Academy of Neurologic Physical Therapy (NeuroPT) provides population-specific guidance for stroke, Parkinson’s, and TBI, including modifications for patients with aphasia or cognitive impairment.

Paediatric patients: Normal walking speeds for children differ significantly from adults. Developmental norms exist for children ages 3-18 years. The “10-meter walk/run test” variant in older pediatric research may allow acceleration (running) rather than walking, which affects interpretation.

Spinal cord injury (SCI) populations: Patients may use walking aids, leg braces, or require hands-on guarding. The test assesses practical walking ability in the presence of these devices, making results more clinically relevant than unassisted norms.

Always document the specific protocol variant, walking aids used, and any assistance provided. This transparency ensures reproducibility and allows comparison within a single patient across time.

Minimal detectable change and clinical significance

Beyond normal values, clinicians must distinguish between measurement error (noise) and genuine clinical change. The minimal detectable change (MDC) is the smallest difference in speed that reflects true functional change rather than test-retest variability.

For healthy older adults, MDC is approximately ±0.15 m/s. For neurological populations (stroke, Parkinson’s), MDC ranges from 0.1-0.20 m/s depending on diagnosis and severity. The minimal clinically important difference (MCID)-the smallest change that patients perceive as meaningful-varies by population and ranges from 0.10-0.25 m/s.

Practical example: A stroke survivor’s gait speed improves from 0.75 to 0.85 m/s over 6 weeks of physical therapy. A 0.10 m/s gain is within the MDC range (measurement error), but may still be clinically meaningful if accompanied by reduced fall risk or improved balance confidence. Conversely, a 0.05 m/s improvement might reflect day-to-day variability rather than true therapeutic benefit.

Conclusion

The 10-meter walk test is a simple, evidence-based outcome measure that quantifies functional mobility across multiple clinical populations. By documenting gait speed consistently and interpreting results against population-specific norms and minimal detectable change thresholds, clinicians gain objective data for treatment planning, progress monitoring, and risk stratification.

A structured digital patient record keeps all 10MWT results and longitudinal outcome data organised and accessible, supporting data-driven clinical decisions and transparent patient communication. Download the free template above to integrate the 10-meter walk test into your clinic today.

Continue your research

Need structured gait assessment forms? Digital forms and intake templates automate patient data collection and reduce manual documentation burden.

Want to track patient outcomes over time? Measurement tracking software centralizes all clinical assessments in one place for easy progress monitoring.

Looking for clinic management solutions? Physical therapy EMR software integrates gait assessments, patient records, billing, and scheduling into one unified platform.

Frequently asked questions